Phase 3Active, not recruiting
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of Subcutaneous Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
- Sponsor
- Swedish Orphan Biovitrum (Industry)
- Enrollment
- 15 enrolled
- Conditions
- Still's Disease, Juvenile Onset; Still's Disease, Adult-Onset
- Interventions
- Anakinra; Placebo
- Ages
- children, adults, older adults
- Registry
- NCT05814159
Full record on ClinicalTrials.gov
From the registry
A study to demonstrate efficacy and safety of anakinra in pediatric and adult Japanese patients with Still's disease (Systemic juvenile idiopathic arthritis \[SJIA\] and Adult-onset Still's disease \[AOSD\]).
Primary outcomes
- An improvement of ≥ 30% from baseline in physician global assessment of disease activity (visual analogue scale [VAS]).
- An improvement of ≥ 30% from baseline in patient/parent global assessment of overall well-being (VAS).
- An improvement of ≥ 30% from baseline in number of joints with active arthritis.
- An improvement of ≥ 30% from baseline in number of joints with limitation of motion.
History
Study completion
Primary completion
Last registry update
Registered
Started